Opportunity ID: 351096

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-TR-23-017
Funding Opportunity Title: Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.350 — National Center for Advancing Translational Sciences
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Nov 22, 2023
Last Updated Date: Nov 22, 2023
Original Closing Date for Applications: Feb 23, 2026
Current Closing Date for Applications: Feb 23, 2026
Archive Date: Mar 31, 2026
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This NOFO provides support using the SBIR cooperative agreement mechanisms for the development of MATChS. Applications considered responsive to this would include those proposing research and development of tools and turnkey technologies for higher throughput automated measures with on-line sensing, rapid acquisition and analysis of data to reduce manual handling. Funded projects will result in an increased availability of miniaturized automated tissue chip platforms for use in drug development and across multiple applications as a major research tool in biomedical research laboratories. As a cooperative agreement, small business concerns (SBCs) will be expected to develop milestones and benchmarks, and work with NIH staff towards progress in the aims of the project to develop an automated system and demonstrable pathways to commercialization.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-23-017.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 351096 Full Announcement-RFA-TR-23-017 -> RFA-TR-23-017-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or before January 24, 2025 PKG00283872 Jan 22, 2024 Jan 24, 2025 View
FORMS-I Use for due dates on or after January 25, 2025 PKG00289262 Nov 27, 2024 Feb 23, 2026 View

Package 1

Mandatory forms

351096 RR_SF424_5_0-5.0.pdf

351096 PHS398_CoverPageSupplement_5_0-5.0.pdf

351096 RR_OtherProjectInfo_1_4-1.4.pdf

351096 PerformanceSite_4_0-4.0.pdf

351096 RR_KeyPersonExpanded_4_0-4.0.pdf

351096 RR_Budget_3_0-3.0.pdf

351096 PHS398_ResearchPlan_5_0-5.0.pdf

351096 SBIR_STTR_Information_3_0-3.0.pdf

351096 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

351096 RR_SubawardBudget30_3_0-3.0.pdf

351096 PHS_AssignmentRequestForm_4_0-4.0.pdf

Package 2

Mandatory forms

351096 RR_SF424_5_0-5.0.pdf

351096 PHS398_CoverPageSupplement_5_0-5.0.pdf

351096 RR_OtherProjectInfo_1_4-1.4.pdf

351096 PerformanceSite_4_0-4.0.pdf

351096 RR_KeyPersonExpanded_4_0-4.0.pdf

351096 RR_Budget_3_0-3.0.pdf

351096 PHS398_ResearchPlan_5_0-5.0.pdf

351096 SBIR_STTR_Information_3_0-3.0.pdf

351096 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

351096 RR_SubawardBudget30_3_0-3.0.pdf

351096 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T15:14:11-05:00

Share This Post, Choose Your Platform!

About the Author: